Ginkgo Bioworks Holdings, Inc. (DNA)
Designs and builds custom cells for medicine, agriculture, and industrial applications.
$7.70+0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-36.8%
The outlook
DNA trades near the lower end of its 52-week range and sits below both its 50- and 200-day moving averages. Analyst coverage leans bullish with an average target around 10% above the current price, though the overall sentiment remains cautious. The stock is in a downtrend with limited near-term momentum.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range19% of the way from its 52-week low to high
Price targetAvg target +10% vs current price
Analyst price target
~12-month · 2 analysts$8.50average target+10.4% vs now
Now $7.70
Low $5.00High $12.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$503.0M
52-wk high
$17.58
52-wk low
$5.37
50-day avg
$8.69
200-day avg
$8.98
Trailing P/E
—